Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction.

@article{Arslan2016AssociationBT,
  title={Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction.},
  author={Akif Arslan and Mehmet Ozaydin and Fatih Aksoy and B Seçkin Arslan and Hasan Aydin Bas and Doğan Erdoğan and Ercan Varol and Abdullah Dogan},
  journal={Medicina},
  year={2016},
  volume={52 2},
  pages={
          104-9
        }
}
BACKGROUND AND AIM Atrial fibrillation (AF) is the most common supraventricular arrhythmia following ST-segment elevation myocardial infarction (STEMI). We evaluated the association between use of previous angiotensin converting enzyme inhibitors and/or angiotensin receptor blockers (renin-angiotensin system [RAS] blockers) and started RAS blockers after MI… CONTINUE READING